Chaim Lebovits - Apr 20, 2023 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
President & Co-CEO
Signature
/s/ Chaim Lebovits
Stock symbol
BCLI
Transactions as of
Apr 20, 2023
Transactions value $
$0
Form type
4
Date filed
4/24/2023, 06:44 AM
Previous filing
Jan 4, 2023
Next filing
Aug 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +75K +40.08% $0.00 262K Apr 20, 2023 Direct F1
holding BCLI Common Stock 2M Apr 20, 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares were fully vested upon grant.
F2 Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.